{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:40:50Z","timestamp":1778740850892,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1208\/s12249-011-9656-4","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T12:01:29Z","timestamp":1309867289000},"page":"909-916","source":"Crossref","is-referenced-by-count":9,"title":["Solution-Mediated Phase Transformation of Haloperidol Mesylate in the Presence of Sodium Lauryl Sulfate"],"prefix":"10.1208","volume":"12","author":[{"given":"Kristyn","family":"Greco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"issue":"4","key":"9656_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/A:1007516718048","volume":"17","author":"BC Hancock","year":"2000","unstructured":"Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res. 2000;17(4):397\u2013404.","journal-title":"Pharm Res"},{"issue":"4","key":"9656_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s11095-005-2504-z","volume":"22","author":"S Li","year":"2005","unstructured":"Li S, Wong S, Sethia S, Almoazen H, Joshi YM, Serajuddin ATM. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH. Pharm Res. 2005;22(4):628\u201335.","journal-title":"Pharm Res"},{"issue":"8","key":"9656_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s11095-006-9032-3","volume":"23","author":"DP McNamara","year":"2006","unstructured":"McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, et al. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res. 2006;23(8):1888\u201397.","journal-title":"Pharm Res"},{"issue":"8","key":"9656_CR4","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/jps.21650","volume":"98","author":"J Brouwers","year":"2009","unstructured":"Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98(8):2549\u201372.","journal-title":"J Pharm Sci"},{"issue":"1815","key":"9656_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1098\/rspa.1985.0043","volume":"398","author":"PT Cardew","year":"1985","unstructured":"Cardew PT, Davey RJ. The kinetics of solvent-mediated phase transformations. Proc R Society of London, Series A: Math, Phys and Eng Sci. 1985;398(1815):415\u201328.","journal-title":"Proc R Society of London, Series A: Math, Phys and Eng Sci"},{"issue":"1\u20133","key":"9656_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0378-5173(92)90144-Q","volume":"85","author":"N Rodriguez-Hornedo","year":"1992","unstructured":"Rodriguez-Hornedo N, Lechuga-Ballesteros D, Wu HJ. Phase transition and heterogeneous\/epitaxial nucleation of hydrated and anhydrous theophylline crystals. Int J Pharm. 1992;85(1\u20133):149\u201362.","journal-title":"Int J Pharm"},{"issue":"7","key":"9656_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1021\/js980490h","volume":"88","author":"N Rodriguez-Hornedo","year":"1999","unstructured":"Rodriguez-Hornedo N, Murphy D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci. 1999;88(7):651\u201360.","journal-title":"J Pharm Sci"},{"issue":"2","key":"9656_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jps.10496","volume":"93","author":"N Rodriguez-Hornedo","year":"2004","unstructured":"Rodriguez-Hornedo N, Murphy D. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J Pharm Sci. 2004;93(2):449\u201360.","journal-title":"J Pharm Sci"},{"issue":"7","key":"9656_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","volume":"59","author":"ATM Serajuddin","year":"2007","unstructured":"Serajuddin ATM. Salt formation to improve drug solubility. Advanced Drug Delivery Reviews. 2007;59(7):603\u201316.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9656_CR10","unstructured":"Stahl PH, Wermuth CG, editors. Handbook of pharmaceutical salts: properties selection and use. Weinheim: Wiley-VCH; 2002."},{"key":"9656_CR11","doi-asserted-by":"publisher","unstructured":"Greco K, McNamara DP, Bogner R. Solution mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug. J Pharm Sci. 2011. doi:\n                    10.1002\/jps.22507\n                    \n                  . 100(7):2755\u20132768.","DOI":"10.1002\/jps.22507"},{"issue":"10","key":"9656_CR12","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/jps.20440","volume":"94","author":"S Li","year":"2005","unstructured":"Li S, Doyle P, Metz S, Royce AE, Serajuddin ATM. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. J Pharm Sci. 2005;94(10):2224\u201331.","journal-title":"J Pharm Sci"},{"issue":"2","key":"9656_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F","volume":"89","author":"J Jinno","year":"2000","unstructured":"Jinno J, Oh D-M, Crison JR, Amidon GL. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J Pharm Sci. 2000;89(2):268\u201374.","journal-title":"J Pharm Sci"},{"issue":"9","key":"9656_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1021\/js930336p","volume":"85","author":"JR Crison","year":"1996","unstructured":"Crison JR, Shah VP, Skelly JP, Amidon GL. Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine. J Pharm Sci. 1996;85(9):1005\u201311.","journal-title":"J Pharm Sci"},{"issue":"3","key":"9656_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/A:1014407421366","volume":"19","author":"ES Kostewicz","year":"2002","unstructured":"Kostewicz ES, Brauns U, Becker R, Dressman JB. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm Res. 2002;19(3):345\u20139.","journal-title":"Pharm Res"},{"issue":"3","key":"9656_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","volume":"60","author":"M Vertzoni","year":"2005","unstructured":"Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm. 2005;60(3):413\u20137.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"9656_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1023\/A:1023493821302","volume":"20","author":"R Chen Linna","year":"2003","unstructured":"Chen Linna R, Wesley James A, Bhattachar S, Ruiz B, Bahash K, Babu Suresh R. Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm Res. 2003;20(5):797\u2013801.","journal-title":"Pharm Res"},{"key":"9656_CR18","volume-title":"Crystallization","author":"JW Mullin","year":"2001","unstructured":"Mullin JW. Crystallization. 4th ed. Oxford: Butterworth-Heinemann; 2001.","edition":"4"},{"issue":"3\/4","key":"9656_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0022-0248(96)00771-3","volume":"172","author":"N Garti","year":"1997","unstructured":"Garti N, Zour H. The effect of surfactants on the crystallization and polymorphic transformation of glutamic acid. J Crys Growth. 1997;172(3\/4):486\u201398.","journal-title":"J Crys Growth"},{"issue":"5","key":"9656_CR20","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1021\/cg1002176","volume":"10","author":"N Huang","year":"2010","unstructured":"Huang N, Rodriguez-Hornedo N. Effect of micellar solubilization on cocrystal solubility and stability. Cryst Growth Des. 2010;10(5):2050\u20133.","journal-title":"Cryst Growth Des"},{"issue":"1","key":"9656_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10837450903499341","volume":"16","author":"K Greco","year":"2011","unstructured":"Greco K, Bergman TL, Bogner R. Design and characterization of a laminar flow-through dissolution apparatus: comparison of hydrodynamic conditions to those of common dissolution techniques. Pharm Dev Technol. 2011;16(1):75\u201387.","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"9656_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.aca.2005.05.069","volume":"548","author":"E Fuguet","year":"2005","unstructured":"Fuguet E, Rafols C, Roses M, Bosch E. Critical micelle concentration of surfactants in aqueous buffered and unbuffered systems. Anal Chim Acta. 2005;548(1\u20132):95\u2013100.","journal-title":"Anal Chim Acta"},{"key":"9656_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-011-1332-8","volume-title":"Handbook of surfactants","author":"MR Portar","year":"1994","unstructured":"Portar MR. Handbook of surfactants. 2nd ed. Glasgow: Chapman and Hall; 1994.","edition":"2"},{"issue":"3","key":"9656_CR24","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1208\/pt050345","volume":"5","author":"A Jain","year":"2004","unstructured":"Jain A, Ran Y, Yalkowsky Samuel H. Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): a technical note. AAPS PharmSciTech. 2004;5(3):e45.","journal-title":"AAPS PharmSciTech"},{"key":"9656_CR25","unstructured":"Shlyankevich A, Sanghvi P, Li H, Ebadi M, Ketsela S, Elcsics G, et al. Sodium lauryl sulfate in dissolution media: adverse effects on tablet disintegration and drug release. AAPS PharmSci. 2003;(S1): Abstract 1304."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-011-9656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-011-9656-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-011-9656-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-011-9656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:48:15Z","timestamp":1559605695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-011-9656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9656"],"URL":"https:\/\/doi.org\/10.1208\/s12249-011-9656-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}